Benoît Laleu

Title: Benoît Laleu: Innovator in Pharmaceutical Chemistry

Introduction

Benoît Laleu is a notable inventor based in Collonges-sous-Salève, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 3 patents to his name, Laleu's work focuses on innovative solutions for health-related issues.

Latest Patents

Laleu's latest patents include groundbreaking research on pyrazoline dione derivatives and pyrazolo piperidine derivatives. The first patent, titled "Pyrazoline dione derivatives as NADPH oxidase inhibitors," relates to the use of these derivatives for the treatment and/or prophylaxis of disorders associated with Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase). The second patent, "Pyrazolo piperidine derivatives as NADPH oxidase inhibitors," similarly addresses the therapeutic potential of these compounds in managing conditions linked to NADPH Oxidase.

Career Highlights

Throughout his career, Benoît Laleu has worked with prominent companies in the pharmaceutical sector, including Genkyotex and Genkyotex Suisse. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Laleu has collaborated with several professionals in his field, including Francesca Gaggini and Patrick Naxos Page. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Benoît Laleu stands out as an influential inventor in pharmaceutical chemistry, with a focus on innovative compounds that address critical health issues. His contributions through patents and collaborations highlight his commitment to advancing medical science.